NANOLEK
About us
  • Team
  • History
  • Strategy, mission, values
  • Honors and awards
  • Education and CSR
  • Occupational Safety and Health
  • Partners
R&D
Products
  • Vaccines
  • Biotechnology products
  • Chemical products
  • Contract manufacture
  • Other products
Manufacturing
  • Biopharmaceuticals
  • Solid dosage forms
  • Quality control
  • Certificates
Press center
  • Company news
    • Company news
    • Photo gallery
    • Media kit
    • Media contacts
  • Photo gallery
  • Media kit
  • Media contacts
Careers
  • Vacancies
    • Vacancies
    • Corporate culture
  • Corporate culture
Contacts
Ещё
    Ask a question
    info@nanolek.ru
    Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
    • Vkontakte
    • Facebook
    • Instagram
    • YouTube
    EN | RU
    NANOLEK
    About us
    • Team
    • History
    • Strategy, mission, values
    • Honors and awards
    • Education and CSR
    • Occupational Safety and Health
    • Partners
    R&D
    Products
    • Vaccines
    • Biotechnology products
    • Chemical products
    • Contract manufacture
    • Other products
    Manufacturing
    • Biopharmaceuticals
    • Solid dosage forms
    • Quality control
    • Certificates
    Press center
    • Company news
    • Photo gallery
    • Media kit
    • Media contacts
    Careers
    • Vacancies
    • Corporate culture
    Contacts
      NANOLEK
      About us
      • Team
      • History
      • Strategy, mission, values
      • Honors and awards
      • Education and CSR
      • Occupational Safety and Health
      • Partners
      R&D
      Products
      • Vaccines
      • Biotechnology products
      • Chemical products
      • Contract manufacture
      • Other products
      Manufacturing
      • Biopharmaceuticals
      • Solid dosage forms
      • Quality control
      • Certificates
      Press center
      • Company news
      • Photo gallery
      • Media kit
      • Media contacts
      Careers
      • Vacancies
      • Corporate culture
      Contacts
        NANOLEK
        EN | RU
        NANOLEK
        • About us
          • Back
          • About us
          • Team
          • History
          • Strategy, mission, values
          • Honors and awards
          • Education and CSR
          • Occupational Safety and Health
          • Partners
        • R&D
        • Products
          • Back
          • Products
          • Vaccines
          • Biotechnology products
          • Chemical products
          • Contract manufacture
          • Other products
        • Manufacturing
          • Back
          • Manufacturing
          • Biopharmaceuticals
          • Solid dosage forms
          • Quality control
          • Certificates
        • Press center
          • Back
          • Press center
          • Company news
            • Back
            • Company news
            • Company news
            • Photo gallery
            • Media kit
            • Media contacts
          • Photo gallery
          • Media kit
          • Media contacts
        • Careers
          • Back
          • Careers
          • Vacancies
            • Back
            • Vacancies
            • Vacancies
            • Corporate culture
          • Corporate culture
        • Contacts
        info@nanolek.ru
        Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
        • Vkontakte
        • Facebook
        • Instagram
        • YouTube

        • NANOLEK

          We protect the lives and health of people, making the world's best technologies available to everyone

          About us Products
        • Prev
        • Next
        Innovation
        Innovative Russian vaccines to ensure the biological protection of the population
        Quality
        Quality medicines at affordable prices
        Technology
        High-tech production in accordance with international standards
        Significance
        Focus on prevention and treatment of socially significant diseases

        Press center

        Subscribe
        • Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib
          Company news
          Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib
          18.06.2021
        • The plant of Nanolek in Kirow Region is about to launch production of the third CoviVac vaccine
          Company news
          The plant of Nanolek in Kirow Region is about to launch production of the third CoviVac vaccine
          26.05.2021
        • Nanolek will invest 5 billion rubles in the full production cycle and proprietary vaccine development by 2024 to become a leader in Russia's vaccine market
          Company news
          Nanolek will invest 5 billion rubles in the full production cycle and proprietary vaccine development by 2024 to become a leader in Russia's vaccine market
          19.05.2021
        • At a Meeting with Russian President Vladimir Putin on March 22, Nanolek Confirms Its Plans to Produce 5 Mln Doses of CoviVac Vaccine by the End of 2021
          Company news
          At a Meeting with Russian President Vladimir Putin on March 22, Nanolek Confirms Its Plans to Produce 5 Mln Doses of CoviVac Vaccine by the End of 2021
          22.03.2021
        • Mikhail Nekrasov, CEO of NANOLEK, attends the XVI Annual Conference "Pharmaceutical Business in Russia"
          Company news
          Mikhail Nekrasov, CEO of NANOLEK, attends the XVI Annual Conference "Pharmaceutical Business in Russia"
          15.03.2021
        • Maxim Stetsyuk, First Deputy General Director of Nanolek, takes part in the scientific conference on COVID-19
          Company news
          Maxim Stetsyuk, First Deputy General Director of Nanolek, takes part in the scientific conference on COVID-19
          12.03.2021
        • NANOLEK continues to expand its portfolio of cancer drugs
          Company news
          NANOLEK continues to expand its portfolio of cancer drugs
          11.03.2021
        • Participants of PHARMA'S COOL-2021 SKOLKOVO dig into GMP standards
          Company news
          Participants of PHARMA'S COOL-2021 SKOLKOVO dig into GMP standards
          05.03.2021
        • Marina Mazurevskaya, Deputy CEO for Legal Affairs and Government Relations Speaks at GR FORCE 2021 GR Director Forum
          Company news
          Marina Mazurevskaya, Deputy CEO for Legal Affairs and Government Relations Speaks at GR FORCE 2021 GR Director Forum
          04.03.2021
        • Svetlana Zakirova, Deputy CEO for Development and Research at NANOLEK, delivered a speech at Pharma's cool in Skolkovo
          Company news
          Svetlana Zakirova, Deputy CEO for Development and Research at NANOLEK, delivered a speech at Pharma's cool in Skolkovo
          03.03.2021
        • NANOLEK sums up the results for 2020
          Company news
          NANOLEK sums up the results for 2020
          26.02.2021
        • NANOLEK and BeiGene: A Collaboration for Cancer Treatment in Russia
          Company news
          NANOLEK and BeiGene: A Collaboration for Cancer Treatment in Russia
          25.02.2021
        About us
        Team
        History
        Strategy, mission, values
        Honors and awards
        Education and CSR
        Occupational Safety and Health
        Partners
        Press center
        Company news
        Photo gallery
        Media kit
        Media contacts
        Manufacturing
        Biopharmaceuticals
        Solid dosage forms
        Quality control
        Certificates
        Compliance
        Privacy policy
        Pharmacovigilance
        Subscribe
        info@nanolek.ru
        Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
        • Vkontakte
        • Facebook
        • Instagram
        • YouTube
        PRIVACY POLICY
        © 2021